Amanote Research

Amanote Research

    RegisterSign In

Dose-Response Study of Ibandronate in the Treatment of Cancer-Associated Hypercalcaemia

British Journal of Cancer - United Kingdom
doi 10.1038/bjc.1997.48
Full Text
Open PDF
Abstract

Available in full text

Categories
Cancer ResearchOncology
Date

January 1, 1997

Authors
SH RalstonD ThiébaudZ HerrmannEU SteinhauerB ThürlimannJ WallsMR LichinitserR RizzollH HagbergHJ HussM Tubiana-HulinJJ Body
Publisher

Springer Science and Business Media LLC


Related search

Treatment of Cancer Associated Hypercalcaemia With Combined Aminohydroxypropylidene Diphosphonate and Calcitonin.

BMJ
1986English

Treatment of Hypercalcaemia Associated With Malignancy.

BMJ
1984English

Ibandronate in the Treatment of Pediatric Osteoporosis

Bone Abstracts
2014English

Hypercalcaemia and Cancer

Postgraduate Medical Journal
Medicine
1963English

Hypercalcaemia Associated With Tuberculosis.

BMJ
1980English

Hypocalcaemic Response to Streptomycin in Malignant Hypercalcaemia

Postgraduate Medical Journal
Medicine
1975English

Paraneoplastic Hypercalcaemia Associated With TCC of Bladder

The Scientific World Journal
BiochemistryMedicineGeneticsMolecular BiologyEnvironmental Science
2004English

Treatment of Hypercalcaemia of Malignancy: Author's Reply

BMJ
1988English

A Phase II Study of Oxaliplatin, Dose-Intense Capecitabine, and High-Dose Bevacizumab in the Treatment of Metastatic Colorectal Cancer

Clinical Colorectal Cancer
OncologyGastroenterology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy